Investigating how inosine-containing dsRNA downregulates gene expression. (360G-Wellcome-084403_Z_07_Z)

£204,818

We recently showed that I-dsRNA specifically binds a stress-complex , which comprises various stress granule (SG) components. Furthermore, we demonstrated that I-dsRNA in cells downregulates both endogenous and reporter gene expression, in trans. We provided evidence that this was the result of both reduced mRNA levels and impaired translation initiation. We therefore proposed a model in which hyper-editing of dsRNAs by ADARs results in downregulation of gene expression via SG formation. W e now plan to carry out experiments aimed at further understanding the proposed model, and to elucidate the mechanistic details. The I-dsRNA stress-complex will be further characterized. We will investigate whether SGs assemble in response to I-dsRNA, and which SG components are important for downregulating gene expression in the presence of I-dsRNA. We will explore the pathway by which I-dsRNA results in degradation of reporter mRNAs, and will identify the nuclease(s) responsible. The mechanism by which I-dsRNA inhibits translation initiation will also be investigated. We will analyze the effect of I-dsRNA on endogenous gene expression. Finally we will look at the potential relationship between ADARs and SGs. A key part of the model predicts that editing of an unknown substrate(s) by ADARs will lead to SG assembly.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 204818
Applicant Surname Scadden
Approval Committee Molecules, Genes and Cells Funding Committee
Award Date 2008-02-20T00:00:00+00:00
Financial Year 2007/08
Grant Programme: Title Project Grant
Internal ID 084403/Z/07/Z
Lead Applicant Dr Deirdre Scadden
Partnership Value 204818
Planned Dates: End Date 2012-06-04T00:00:00+00:00
Planned Dates: Start Date 2009-01-05T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East of England